Atrophic Gastritis Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Atrophic Gastritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

The GAstric Precancerous Conditions Study

Gastric CancerHelicobacter Pylori InfectionAtrophic Gastritis+1 more
Stanford University600 enrolled1 locationNCT04191551
Recruiting
Phase 4

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

Gastric CancerHelicobacter Pylori InfectionsAtrophic Gastritis
International Agency for Research on Cancer30,000 enrolled1 locationNCT02047994
Recruiting

Atrophic Gastritis Predicts the Risk of Gastric Cancer

Atrophic Gastritis
Shanghai Jiao Tong University School of Medicine2,042 enrolled1 locationNCT06203327
Recruiting

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Gastric CancerAtrophic GastritisIntestinal Metaplasia
Chinese University of Hong Kong1,300 enrolled1 locationNCT04840056
Recruiting

AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis

Artificial IntelligenceAtrophic GastritisEndoscopy
Shandong University1,500 enrolled1 locationNCT05916014
Recruiting
Not Applicable

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

Atrophic Gastritis With Low-grade Intraepithelial Neoplasia
Peking University First Hospital144 enrolled1 locationNCT06324825
Recruiting
Not Applicable

SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up

Gastric CancerAtrophic GastritisGastric Dysplasia+1 more
Instituto Portugues de Oncologia, Francisco Gentil, Porto912 enrolled1 locationNCT04613570
Recruiting

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Gastric CancerAtrophic GastritisGastric Dysplasia+1 more
University of Latvia5,000 enrolled5 locationsNCT04022109